EMEDElectromedical Technologies, Inc.

About Electromedical Technologies, Inc. (EMED)

Electromedical Technologies, Inc. (EMED) is a Medical Devices company headquartered in Scottsdale, AZ, United States whose shares trade over-the-counter on the Pink tier.

We are a bioelectronics manufacturing company and our mission is to improve global wellness for people suffering from various painful conditions by relieving chronic and acute pain using energy, frequency and vibration as an alternative to pharmaceuticals; and one day, read and modify electrical signals passing along nerves in the body, to restore long-term health. We believe that we do this by delivering innovative solutions providing fast and long lasting pain relief across the broadest range of ailments. We engineer simple-to-use bioelectronics therapy devices, which send a proprietary sequence of electrical signals. We believe our devices have proven to be highly effective over the past decade and have the technological capability to be used in medical research.

Products and services

Electromedical Technologies is a bioelectronics manufacturing and marketing company. We offer U.S. Food and Drug Administration (FDA) cleared medical devices for pain management. Our Wellness Pro product received FDA clearance on July 6, 2007 (FDA K062616) as a Class II Medical Device, under the 510(K) clearance process. Bioelectronics is a developing field of “electronic” medicine, which uses electrical impulses over the body’s neural circuitry to try to alleviate pain without drugs. The human body is controlled by electrical signals sent through the nervous system, which can become distorted after accidents or as the result of disease. The field of bioelectronic medicine aims to safely correct irregularities in the nervous system, by modifying the electrical language of the body related to pain relief.

EMED key facts

Ticker symbol

EMED

Market tier

Pink

Sector

Healthcare

Industry

Medical Devices

Headquarters

Scottsdale, AZ, United States

Country of incorporation

US

Employees

9

Estimated market cap

$746.4K (as of Apr 10, 2025)

Shares outstanding

1,865,938,492

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Electromedical Technologies, Inc. leadership

• Matthew Wolfson — CEO, CFO
• Tad Mailander — Counsel

Explore more: Medical Devices stocks · Healthcare sector · Pink stocks · OTC stocks starting with E